(Q35538803)

8 August 2017

1 reference

title

Antioxidant treatment in Alzheimer's disease: current state (English)

1 reference

https://api.crossref.org/works/10.1385/JMN:21:1:1

8 August 2017

Antioxidant Treatment in Alzheimer's Disease: Current State (English)

1 reference

12 March 2024

0 references

Yossi Gilgun-Sherki

1

1 reference

8 August 2017

Eldad Melamed

series ordinal

2

1 reference

8 August 2017

Daniel Offen

series ordinal

3

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14500988

12 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://www.springerlink.com/index/pdf/10.1385/JMN:21:1:1

1 reference

https://api.crossref.org/works/10.1385/JMN:21:1:1

Journal of Molecular Neuroscience

12 March 2024

published in

1 reference

8 August 2017

volume

21

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

1-11

1 reference

Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid

8 August 2017

cites work

1 reference

12 December 2020

Role of free radicals in aging and disease

1 reference

12 December 2020

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

1 reference

12 December 2020

Mild cognitive impairment in older people.

1 reference

12 December 2020

Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy

1 reference

12 December 2020

Current status of antioxidant therapy for Alzheimer's Disease

1 reference

12 December 2020

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

1 reference

12 December 2020

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease

1 reference

12 December 2020

Human longevity and aging: possible role of reactive oxygen species

1 reference

12 December 2020

Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

12 December 2020

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study

1 reference

12 December 2020

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

12 December 2020

Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease

1 reference

12 December 2020

Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease

1 reference

12 December 2020

Free radicals in Alzheimer's dementia: currently available therapeutic strategies

1 reference

12 December 2020

Oxidative damage is the earliest event in Alzheimer disease

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

12 December 2020

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

12 December 2020

Aging: is oxidative stress a marker or is it causal?

1 reference

12 December 2020

Mitochondria, free radicals, and neurodegeneration

1 reference

12 December 2020

Vitamin E and C supplements and risk of dementia

1 reference

12 December 2020

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

1 reference

12 December 2020

Alzheimer's disease and oxygen radicals: new insights

1 reference

12 December 2020

The molecular bases of Alzheimer's disease and other neurodegenerative disorders

1 reference

12 December 2020

Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease

1 reference

12 December 2020

The role of excitotoxicity in neurodegenerative disease: implications for therapy

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation

1 reference

12 December 2020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

12 December 2020

Glutamate transmission and toxicity in Alzheimer's disease

1 reference

12 December 2020

Guidelines for managing Alzheimer's disease: part I. Assessment

1 reference

12 December 2020

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

1 reference

12 December 2020

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

12 December 2020

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

12 December 2020

Immunization treatment approaches in Alzheimer's and prion diseases.

1 reference

12 December 2020

Pharmacotheraphy for Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

1 reference

12 December 2020

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

12 December 2020

Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease

1 reference

12 December 2020

Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives

1 reference

12 December 2020

1 reference

12 December 2020

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress

1 reference

12 December 2020

Antioxidants and Alzheimer's disease: from bench to bedside (and back again).

1 reference

12 December 2020

Intake of flavonoids and risk of dementia

1 reference

12 December 2020

Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias

1 reference

12 December 2020

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

12 December 2020

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

12 December 2020

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

12 December 2020

Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro

1 reference

12 December 2020

Oxidative stress and Alzheimer disease

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:21:1:1

1 reference

Dimensions Publication ID

8 August 2017

1043129872

0 references

1 reference